0 items USD 0.00Search
- Did you mean
- non small cell long cancer
Your search for "non small cell lung cancer" gave back 238 results.
Global monoclonal antibodies market will reach $329.6 billion by 2030, growing by 10.9% annually over 2020-2030, driven by the increasing incidences...
Catalog:
Grace Market Data
December 2021
Price: USD 3,200.00
Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem...
Catalog:
iGATE
May 2017
Price: USD 1,090.00
Proton Therapy is one of the most technologically advanced treatments for cancer. With an increasing incidence of cancer, there is a definite need...
Catalog:
iGATE
May 2017
Price: USD 1,050.00
Proton Therapy is one of the most technologically advanced treatments for cancer. Unfortunately, the access to proton therapy is limited for a vast...
Catalog:
iGATE
May 2017
Price: USD 1,050.00
The report “Global Proton Therapy Market Outlook 2021” provides an in-depth analysis of global proton therapy treatment market with focus on major...
Catalog:
Rockville Research
December 2016
Price: USD 800.00
Proton therapy is a relatively new, albeit expensive, strategy for treating certain types of cancers (e.g. breast, prostate, ocular), currently...
Catalog:
iGATE
May 2017
Price: USD 1,050.00
South Korea proton therapy market is anticipated to almost three-fold during the period 2016 - 2022. The number of patients treated with Proton...
Catalog:
iGATE
May 2017
Price: USD 1,090.00
Asia Pacific minimal residual disease (MRD) testing market will grow by 15.5% annually with a total addressable market cap of $4,575.0 million over...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021 and will grow by 11.8% annually over 2021-2031, driven by...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
North America minimal residual disease (MRD) testing market is projected to grow by 11.1% annually in the forecast period and reach $ 1,056.1 million...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. It is...
Catalog:
iGATE
July 2017
Price: USD 1,950.00
France represents a huge untapped market opportunity for proton therapy. Proton therapy is an advanced treatment of tumors which minimizes the risks...
Catalog:
iGATE
May 2017
Price: USD 1,050.00
Japan proton therapy market is anticipated to grow at a CAGR of around 18% during the period 2017 – 2022. The number of proton therapy centers is...
Catalog:
iGATE
May 2017
Price: USD 1,090.00
Global minimal residual disease (MRD) testing market will reach $ 2,858.1 million by 2031, growing by 12.4% annually over 2021-2031, driven by the...
Catalog:
Grace Market Data
May 2022
Price: USD 3,480.00
Germany is the largest market for proton therapy in the European region. Currently, six proton therapy centers are operational in Germany. Still,...
Catalog:
iGATE
May 2017
Price: USD 1,050.00
